Emcure Pharmaceuticals shares gained 2% after its subsidiary entered into a partnership with WiQo to distribute the skin-tightening product ‘PRX-PLUS’ in India, tapping into the growing dermatology market.
Emcure Pharmaceuticals shares gained 2% after its subsidiary entered into a partnership with WiQo to distribute the skin-tightening product ‘PRX-PLUS’ in India, tapping into the growing dermatology market.